Business Card for Kinnari Pandya:


Director
New York, NY area
Email Avail: 3 Day Free Trial


New York
New York, NY 10017

Tel: (212) 733-2323

Last updated on 2018-01-11


About Kinnari Pandya:

Kinnari Pandya works as an Director for Pfizer at New York, NY. The company's webpage is http://www.pfizer.com. For email, phone number and executive profiles for Director and other executives of Pfizer at New York, NY, check Pfizer at Joesdata.com. Not the Kinnari Pandya you are looking for? Do a quick search in our website and find other people named Kinnari Pandya.
Kinnari Pandya's Work History:
No information available..

Kinnari Pandya's Education:
No information available..

Kinnari Pandya's Co-workers:
As of December 15, 2019, Kinnari Pandya has 3684 co-workers under the company name Pfizer at Joesdata.com.

About Pfizer:


Warning: mysqli_fetch_assoc() expects parameter 1 to be mysqli_result, boolean given in /home2/joesdata/public_html/login/executivedetails.php on line 392
Pfizer is located at New York, New York, NY 10017. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-20 19:18:44
Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
2018-09-20 17:30:41
Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
2018-09-18 19:18:48
New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting
2018-09-18 19:12:50
Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts
2018-09-18 17:30:47
New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting
2018-09-18 17:30:45
Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts
2018-09-15 18:54:32
Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress
2018-09-15 17:30:58
Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress
2018-09-06 18:54:14
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
2018-09-06 17:30:44
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

People in the same industry: